US Broker Ratings

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Steady Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to be a mainstay for investors seeking stability and growth in the volatile drug..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant Shows 11% Upside Potential and Robust Earnings

Cencora, Inc. (NYSE: COR), a titanic entity in the healthcare sector, is making waves in the medical distribution industry. With a market capitalization of $69.88 billion,..

The Cigna Group (CI) Stock Analysis: Unveiling a 19.27% Potential Upside for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare plans industry, offers a range of insurance and related services primarily in the United States. With..

Eli Lilly (LLY) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Highlight Growth Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its robust financial performance and strategic partnerships. With..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a 9.12% Potential Upside in the Healthcare Sector

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, is capturing investor attention with its substantial market cap of $394.14 billion and a promising potential..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Growth Potential

Novo Nordisk A/S (NVO) stands as a formidable player in the healthcare sector, specializing in drug manufacturing. Headquartered in Bagsvaerd, Denmark, the company is renowned for..

Abbott Laboratories (ABT) Stock Analysis: Healthcare Giant Offers 22.82% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with a substantial market capitalization of $190.23 billion. Specializing in medical..

Autolus Therapeutics (AUTL) Stock Analysis: A Biotech Gem with a 550% Upside Potential

For investors with a penchant for high-risk, high-reward scenarios, Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling case. A clinical-stage biopharmaceutical company based in the United..

AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential in Innovative Mental Health Treatments

AtaiBeckley Inc. (NASDAQ: ATAI) is garnering significant attention in the biotechnology sector, particularly due to its focus on pioneering treatments for mental health disorders. With an..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 9.93% Potential Upside

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector focusing on medical devices, is navigating a challenging landscape with its innovative proteomics and..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a Potential 93.72% Upside

AngioDynamics, Inc. (NASDAQ: ANGO) has emerged as a noteworthy player in the medical technology sector, captivating investor interest with its expansive portfolio of innovative medical devices..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech with Nearly 95% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company specializing in central nervous system (CNS) disorders, is garnering significant attention in the investment community. With a..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech Bet with 65.85% Upside Potential

MBX Biosciences, Inc. (MBX) is rapidly gaining attention within the biotech investment community. With a current market capitalization of $1.65 billion, MBX stands as a formidable..

Verastem, Inc. (VSTM): Investor Outlook with a Potential Upside of 151.56%

Verastem, Inc. (NASDAQ: VSTM), a rising star in the biotechnology sector, is capturing the attention of savvy investors seeking significant growth opportunities. Specializing in the development..

Oruka Therapeutics, Inc. (ORKA) Stock Report: Biotechnology Pioneer Poised for 57.87% Upside

In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is carving a niche with its innovative approach to tackling inflammatory and immunological conditions. With..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a Potential 91.82% Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a key player in the healthcare sector with a focus on medical devices, offers an intriguing prospect for investors seeking growth opportunities...

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Potential 124% Upside in Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA) is a name that has been gaining traction in the biotechnology sector, primarily due to its promising pipeline and strategic collaborations...

PureTech Health plc (PRTC) Investor Outlook: Unveiling a 542.70% Revenue Growth in the Biotech Arena

In the dynamic landscape of biotechnology, PureTech Health plc (PRTC) is emerging as a noteworthy player, making significant strides in the healthcare sector. Based in Boston,..

Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 648% Potential Upside

Humacyte, Inc. (NASDAQ: HUMA) is a compelling player in the biotechnology sector, drawing investor attention with its innovative approach to bioengineered human tissues and an impressive..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Evaluating a 13.45% Upside Potential Amidst Sector Challenges

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, specializes in providing preparedness and response solutions for a variety of public health threats...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds